Literature DB >> 9407390

High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR.

M Méndez1, F Souazé, M Nagano, P A Kelly, W Rostène, P Forgez.   

Abstract

Neurotensin (NT) is widely distributed in the central nervous system (CNS) and peripheral tissues, and its actions are mediated by a specific family of G protein-coupled receptors. In this study, the authors have measured the levels of gene expression of the high-affinity neurotensin receptor (NTR) with quantitative reverse-transcriptase-polymerase chain reaction (RT-PCR). In the rat brain, the highest quantities of NTR mRNA were found in the ventral mesencephalon and in the hypothalamus. Surprisingly, almost identical quantities were detected in both structures, despite results from in situ hybridization studies revealing a low expression of NTR mRNA in the hypothalamus. The RT-PCR data suggest that large scale NTR mRNA synthesis is occurring in restrictive hypothalamic nuclei. Intermediate levels of expression were detected in the prefrontal cortex and striatum, and scant levels in the cerebellum. In peripheral tissues, the highest levels of NTR mRNA were detected in the colon, followed by the liver, and then duodenum and pancreas. In this study, the sensitivity and the accuracy of the quantitative RT-PCR method provided the means to estimate the relative distribution of NTR mRNA between brain structures and peripheral tissues. Therefore, this study promotes a better understanding of the localization of NTR synthesis in relationship with the various physiological effects of NT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407390     DOI: 10.1007/BF02736853

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor.

Authors:  H Boudin; D Pélaprat; W Rostène; A Beaudet
Journal:  J Comp Neurol       Date:  1996-09-09       Impact factor: 3.215

2.  Quantitative RT-PCR: limits and accuracy.

Authors:  F Souazé; A Ntodou-Thomé; C Y Tran; W Rostène; P Forgez
Journal:  Biotechniques       Date:  1996-08       Impact factor: 1.993

3.  Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.

Authors:  D Herve; J P Tassin; J M Studler; C Dana; P Kitabgi; J P Vincent; J Glowinski; W Rostene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E-115.

Authors:  R M Snider; C Forray; M Pfenning; E Richelson
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

5.  Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.

Authors:  Y Masuo; M N Montagne; D Pélaprat; D Scherman; W Rostène
Journal:  Brain Res       Date:  1990-06-18       Impact factor: 3.252

6.  Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro.

Authors:  E Audinat; J M Hermel; F Crépel
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Stimulation of hepatocyte DNA synthesis by neurotensin.

Authors:  K Hasegawa; S Kar; B I Carr
Journal:  J Cell Physiol       Date:  1994-02       Impact factor: 6.384

9.  Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors.

Authors:  A Brouard; D Pelaprat; C Dana; M Vial; A M Lhiaubet; W Rostène
Journal:  J Neurosci       Date:  1992-04       Impact factor: 6.167

10.  Neurotensin: topographical distribution in rat brain by immunohistochemistry.

Authors:  L Jennes; W E Stumpf; P W Kalivas
Journal:  J Comp Neurol       Date:  1982-09-20       Impact factor: 3.215

View more
  8 in total

1.  Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway.

Authors:  Cecilia Ratner; Zhenyan He; Kaare V Grunddal; Louise J Skov; Bolette Hartmann; Fa Zhang; Annette Feuchtinger; Anette Bjerregaard; Christina Christoffersen; Matthias H Tschöp; Brian Finan; Richard D DiMarchi; Gina M Leinninger; Kevin W Williams; Christoffer Clemmensen; Birgitte Holst
Journal:  Diabetes       Date:  2019-04-01       Impact factor: 9.461

2.  Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats.

Authors:  Stelios F Assimakopoulos; Athanassios C Tsamandas; Ilias H Alexandris; Christos Georgiou; Constantine E Vagianos; Chrisoula D Scopa
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

3.  Activation of neurotensin receptor type 1 attenuates locomotor activity.

Authors:  Chelsea A Vadnie; David J Hinton; Sun Choi; YuBin Choi; Christina L Ruby; Alfredo Oliveros; Miguel L Prieto; Jun Hyun Park; Doo-Sup Choi
Journal:  Neuropharmacology       Date:  2014-06-11       Impact factor: 5.250

Review 4.  Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.

Authors:  T Antonelli; M C Tomasini; K Fuxe; L F Agnati; S Tanganelli; L Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2006-09-19       Impact factor: 3.575

5.  Effects of pallidal neurotensin on haloperidol-induced parkinsonian catalepsy: behavioral and electrophysiological studies.

Authors:  Yan Xue; Lei Chen
Journal:  Neurosci Bull       Date:  2010-10       Impact factor: 5.203

6.  Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.

Authors:  Maria Lazarova; Andrey Popatanasov; Radoslav Klissurov; Svetlana Stoeva; Tamara Pajpanova; Reni Kalfin; Lyubka Tancheva
Journal:  J Mol Neurosci       Date:  2018-10-30       Impact factor: 3.444

Review 7.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

8.  Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.

Authors:  Rosa A Castillo-Rodríguez; Martha L Arango-Rodríguez; Lourdes Escobedo; Daniel Hernandez-Baltazar; Anne Gompel; Patricia Forgez; Daniel Martínez-Fong
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.